Dogwood Therapeutics Inc. (DWTX)
NASDAQ: DWTX
· Real-Time Price · USD
4.82
-0.08 (-1.63%)
At close: Sep 18, 2025, 3:59 PM
4.96
2.90%
After-hours: Sep 18, 2025, 07:35 PM EDT
Dogwood Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 13.4M | 17.54M | 14.85M | 2.04M | 3.02M | 2.38M | 3.32M | 4.79M | 4.59M | 5.33M | 7.03M | 9.79M | 7.7M | 11.35M | 14.01M | 19.19M | 21.84M | 24.59M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 19.13K | 18.15K | 18.13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 43.52K | 71.59K | 28.01K | 20.84K | 35.07K | 52.24K | 3.56K | 18.82K | 32.11K | 53.91K | 7.29K | 13.68K | 25.38K | 34.07K | 863.00 | 21.08K | 757.00 | n/a |
Total Current Assets | 14.7M | 19.16M | 16.54M | 2.28M | 3.64M | 3.22M | 4.17M | 5.25M | 5.21M | 6.52M | 8.37M | 10.86M | 9.04M | 12.55M | 15.78M | 20.11M | 23.76M | 28.27M |
Property-Plant & Equipment | 207.14K | 209.66K | 222.65K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 81.76M | 77.59M | 77.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 81.99M | 77.82M | 84.67M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Assets | 96.69M | 96.98M | 94.31M | 2.28M | 3.64M | 3.22M | 4.17M | 5.25M | 5.21M | 6.52M | 8.37M | 10.86M | 9.04M | 12.55M | 15.78M | 20.11M | 23.76M | 28.27M |
Account Payables | n/a | 1.15M | 1.23M | 454.96K | 217.76K | 196.76K | 111.91K | 205.37K | 214.31K | 135.09K | 573.16K | 679.42K | 665.54K | 330.69K | 353.86K | 483.5K | 262.59K | 614.66K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 44.19K |
Short-Term Debt | 54.5K | 50.72K | 49.7K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 1.33M | 1.07M | 687.59K | n/a | 55.92K | 93.97K | n/a | 46.8K | 62.73K | 93.15K | 159.7K | 261.35K | 346.5K | 236.85K | 532.68K | 459.06K | 345.31K | 226.93K |
Total Current Liabilities | 1.89M | 2.58M | 3.18M | 1.33M | 500.08K | 570.08K | 358.55K | 487.14K | 520.03K | 549.29K | 1.04M | 1.63M | 1.9M | 1.88M | 1.28M | 1.23M | 906.26K | 1.17M |
Long-Term Debt | 75.66M | 75.66M | 15.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 87.93M | 87.32M | 26.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Liabilities | 89.81M | 89.9M | 30.03M | 1.33M | 500.08K | 570.08K | 358.55K | 487.14K | 520.03K | 549.29K | 1.04M | 1.63M | 1.9M | 1.88M | 1.28M | 1.23M | 906.26K | 1.17M |
Total Debt | 75.85M | 75.85M | 15.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Book Value | 6.88M | 7.09M | 64.28M | 949.43K | 3.14M | 2.65M | 3.81M | 4.76M | 4.69M | 5.97M | 7.33M | 9.22M | 7.14M | 10.67M | 14.5M | 18.88M | 22.86M | 27.11M |
Book Value Per Share | 3.60 | 4.92 | 49.05 | 0.86 | 3.42 | 3.45 | 4.94 | 6.23 | 6.37 | 8.14 | 9.99 | 25.07 | 21.43 | 32.03 | 43.52 | 56.66 | 68.60 | 81.39 |
Common Stock | 191.00 | 191.00 | 133.00 | 111.00 | 2.78K | 1.93K | 77.00 | 1.93K | 1.86K | 1.83K | 1.83K | 1.83K | 833.00 | 833.00 | 833.00 | 833.00 | 833.00 | 833.00 |
Retained Earnings | -88.55M | -84.74M | -73.82M | -66.09M | -63.81M | -62.76M | -61.47M | -60.37M | -59.13M | -57.69M | -56.17M | -54.13M | -51.55M | -47.89M | -43.93M | -39.41M | -35.3M | -31.02M |
Comprehensive Income | -267.29K | -3.8M | -3.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 14.15M | 7.09M | 64.28M | 949.43K | 3.14M | 2.65M | 3.81M | 4.76M | 4.69M | 5.97M | 7.33M | 9.22M | 7.14M | 10.67M | 14.5M | 18.88M | 22.86M | 27.11M |
Total Investments | 19.13K | 18.15K | 18.13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |